Compared with ERBB2 wild-type tumors, ERBB2ΔEx16+ mammary tumors exhibit a higher degree of intratumoral heterogeneity as shown by distinct signaling and gene expression profiles associated with the activation of tumor initiation and progression (14, 31). Here, ERBB2 is linked to breast cancer.